PR Newswire Clinical TrialsOriginal article
Onkos Surgical® expands access to NanoCept® Antibacterial Technology for patients requiring total femoral replacement
NanoCept Antibacterial TechnologyELEOS Total Femoral AdapterPositive
AI Analysis
Summary
Onkos Surgical announced the market release of the ELEOS Total Femoral Adapter with NanoCept Antibacterial Technology, expanding access for patients requiring total femoral replacement. The product combines orthopedic implant technology with antibacterial coating.
Outcome Details
Market release of ELEOS Total Femoral Adapter with NanoCept Antibacterial Technology
Importance:3/10
Sentiment:
0.60
product launchorthopedicantibacterial technologymedical device
Read the original article
Published by PR Newswire Clinical Trials on September 17, 2026 12:03 PM